Authors:
Poovorawan, Y
Theamboonlers, A
Vimolket, T
Sinlaparatsamee, S
Chaiear, K
Siraprapasiri, T
Khwanjaipanich, S
Owatanapanich, S
Hirsch, P
Chunsuttiwat, S
Citation: Y. Poovorawan et al., Impact of hepatitis B immunisation as part of the EPI, VACCINE, 19(7-8), 2000, pp. 943-949
Authors:
Tangkijvanich, P
Vimolket, T
Theamboonlers, A
Kullavanijaya, P
Suwangool, P
Poovorawan, Y
Citation: P. Tangkijvanich et al., Serum interleukin-6 and interferon-gamma levels in patients with hepatitisB-associated chronic liver disease, A P J ALLER, 18(2), 2000, pp. 109-114
Authors:
Poovorawan, Y
Theamboonlers, A
Hirsch, P
Vimolket, T
Sinlaparatsamee, S
Chaiear, K
Siraprapasiri, T
Khwanjaipanich, S
Owatanapanich, S
Chunsuttiwat, S
Citation: Y. Poovorawan et al., Persistence of antibodies to the surface antigen of the hepatitis B virus (anti-HBs) in children subjected to the Expanded Programme on Immunization (EPI), including hepatitis-B vaccine, in Thailand, ANN TROP M, 94(6), 2000, pp. 615-621
Authors:
Poovorawan, Y
Kosuwon, P
Sutra, S
Theamboonlers, A
Vimolket, T
Safary, A
Citation: Y. Poovorawan et al., Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents, A P J ALLER, 16(2-3), 1998, pp. 111-117